Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Dermatology OTC medications market report explains the definition, types, applications, major countries, and major players of the Dermatology OTC medications market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Sisley Paris
Shiseido
Amway
Proctor & Gamble
loreal
Lotus Herbals
Clinique Laboratories
Clarins
Revlon
Sebapharma
Avon Products
Edgewell Personal Care
COOLA SUNCARE
Beiersdorf
Lancaster Beauty
Bayer
Obagi Medical Products
Johnson & Johnson
Avene
By Type:
Sun screens
Anti-aging
Wrinkle cream
Acne Treatment
others
By End-User:
male
female
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Dermatology OTC medications Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Dermatology OTC medications Outlook to 2028- Original Forecasts
-
2.2 Dermatology OTC medications Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Dermatology OTC medications Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Dermatology OTC medications Market- Recent Developments
-
6.1 Dermatology OTC medications Market News and Developments
-
6.2 Dermatology OTC medications Market Deals Landscape
7 Dermatology OTC medications Raw Materials and Cost Structure Analysis
-
7.1 Dermatology OTC medications Key Raw Materials
-
7.2 Dermatology OTC medications Price Trend of Key Raw Materials
-
7.3 Dermatology OTC medications Key Suppliers of Raw Materials
-
7.4 Dermatology OTC medications Market Concentration Rate of Raw Materials
-
7.5 Dermatology OTC medications Cost Structure Analysis
-
7.5.1 Dermatology OTC medications Raw Materials Analysis
-
7.5.2 Dermatology OTC medications Labor Cost Analysis
-
7.5.3 Dermatology OTC medications Manufacturing Expenses Analysis
8 Global Dermatology OTC medications Import and Export Analysis (Top 10 Countries)
-
8.1 Global Dermatology OTC medications Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Dermatology OTC medications Export by Region (Top 10 Countries) (2017-2028)
9 Global Dermatology OTC medications Market Outlook by Types and Applications to 2022
-
9.1 Global Dermatology OTC medications Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Sun screens Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Anti-aging Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Wrinkle cream Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Acne Treatment Consumption and Growth Rate (2017-2022)
-
9.1.5 Global others Consumption and Growth Rate (2017-2022)
-
9.2 Global Dermatology OTC medications Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global male Consumption and Growth Rate (2017-2022)
-
9.2.2 Global female Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Dermatology OTC medications Market Analysis and Outlook till 2022
-
10.1 Global Dermatology OTC medications Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Dermatology OTC medications Consumption (2017-2022)
-
10.2.2 Canada Dermatology OTC medications Consumption (2017-2022)
-
10.2.3 Mexico Dermatology OTC medications Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Dermatology OTC medications Consumption (2017-2022)
-
10.3.2 UK Dermatology OTC medications Consumption (2017-2022)
-
10.3.3 Spain Dermatology OTC medications Consumption (2017-2022)
-
10.3.4 Belgium Dermatology OTC medications Consumption (2017-2022)
-
10.3.5 France Dermatology OTC medications Consumption (2017-2022)
-
10.3.6 Italy Dermatology OTC medications Consumption (2017-2022)
-
10.3.7 Denmark Dermatology OTC medications Consumption (2017-2022)
-
10.3.8 Finland Dermatology OTC medications Consumption (2017-2022)
-
10.3.9 Norway Dermatology OTC medications Consumption (2017-2022)
-
10.3.10 Sweden Dermatology OTC medications Consumption (2017-2022)
-
10.3.11 Poland Dermatology OTC medications Consumption (2017-2022)
-
10.3.12 Russia Dermatology OTC medications Consumption (2017-2022)
-
10.3.13 Turkey Dermatology OTC medications Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Dermatology OTC medications Consumption (2017-2022)
-
10.4.2 Japan Dermatology OTC medications Consumption (2017-2022)
-
10.4.3 India Dermatology OTC medications Consumption (2017-2022)
-
10.4.4 South Korea Dermatology OTC medications Consumption (2017-2022)
-
10.4.5 Pakistan Dermatology OTC medications Consumption (2017-2022)
-
10.4.6 Bangladesh Dermatology OTC medications Consumption (2017-2022)
-
10.4.7 Indonesia Dermatology OTC medications Consumption (2017-2022)
-
10.4.8 Thailand Dermatology OTC medications Consumption (2017-2022)
-
10.4.9 Singapore Dermatology OTC medications Consumption (2017-2022)
-
10.4.10 Malaysia Dermatology OTC medications Consumption (2017-2022)
-
10.4.11 Philippines Dermatology OTC medications Consumption (2017-2022)
-
10.4.12 Vietnam Dermatology OTC medications Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Dermatology OTC medications Consumption (2017-2022)
-
10.5.2 Colombia Dermatology OTC medications Consumption (2017-2022)
-
10.5.3 Chile Dermatology OTC medications Consumption (2017-2022)
-
10.5.4 Argentina Dermatology OTC medications Consumption (2017-2022)
-
10.5.5 Venezuela Dermatology OTC medications Consumption (2017-2022)
-
10.5.6 Peru Dermatology OTC medications Consumption (2017-2022)
-
10.5.7 Puerto Rico Dermatology OTC medications Consumption (2017-2022)
-
10.5.8 Ecuador Dermatology OTC medications Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Dermatology OTC medications Consumption (2017-2022)
-
10.6.2 Kuwait Dermatology OTC medications Consumption (2017-2022)
-
10.6.3 Oman Dermatology OTC medications Consumption (2017-2022)
-
10.6.4 Qatar Dermatology OTC medications Consumption (2017-2022)
-
10.6.5 Saudi Arabia Dermatology OTC medications Consumption (2017-2022)
-
10.6.6 United Arab Emirates Dermatology OTC medications Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Dermatology OTC medications Consumption (2017-2022)
-
10.7.2 South Africa Dermatology OTC medications Consumption (2017-2022)
-
10.7.3 Egypt Dermatology OTC medications Consumption (2017-2022)
-
10.7.4 Algeria Dermatology OTC medications Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Dermatology OTC medications Consumption (2017-2022)
-
10.8.2 New Zealand Dermatology OTC medications Consumption (2017-2022)
11 Global Dermatology OTC medications Competitive Analysis
-
11.1 Sisley Paris
-
11.1.1 Sisley Paris Company Details
-
11.1.2 Sisley Paris Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Sisley Paris Dermatology OTC medications Main Business and Markets Served
-
11.1.4 Sisley Paris Dermatology OTC medications Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Shiseido
-
11.2.1 Shiseido Company Details
-
11.2.2 Shiseido Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Shiseido Dermatology OTC medications Main Business and Markets Served
-
11.2.4 Shiseido Dermatology OTC medications Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Amway
-
11.3.1 Amway Company Details
-
11.3.2 Amway Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Amway Dermatology OTC medications Main Business and Markets Served
-
11.3.4 Amway Dermatology OTC medications Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Proctor & Gamble
-
11.4.1 Proctor & Gamble Company Details
-
11.4.2 Proctor & Gamble Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Proctor & Gamble Dermatology OTC medications Main Business and Markets Served
-
11.4.4 Proctor & Gamble Dermatology OTC medications Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 loreal
-
11.5.1 loreal Company Details
-
11.5.2 loreal Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 loreal Dermatology OTC medications Main Business and Markets Served
-
11.5.4 loreal Dermatology OTC medications Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Lotus Herbals
-
11.6.1 Lotus Herbals Company Details
-
11.6.2 Lotus Herbals Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Lotus Herbals Dermatology OTC medications Main Business and Markets Served
-
11.6.4 Lotus Herbals Dermatology OTC medications Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Clinique Laboratories
-
11.7.1 Clinique Laboratories Company Details
-
11.7.2 Clinique Laboratories Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Clinique Laboratories Dermatology OTC medications Main Business and Markets Served
-
11.7.4 Clinique Laboratories Dermatology OTC medications Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Clarins
-
11.8.1 Clarins Company Details
-
11.8.2 Clarins Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Clarins Dermatology OTC medications Main Business and Markets Served
-
11.8.4 Clarins Dermatology OTC medications Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Revlon
-
11.9.1 Revlon Company Details
-
11.9.2 Revlon Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Revlon Dermatology OTC medications Main Business and Markets Served
-
11.9.4 Revlon Dermatology OTC medications Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Sebapharma
-
11.10.1 Sebapharma Company Details
-
11.10.2 Sebapharma Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Sebapharma Dermatology OTC medications Main Business and Markets Served
-
11.10.4 Sebapharma Dermatology OTC medications Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Avon Products
-
11.11.1 Avon Products Company Details
-
11.11.2 Avon Products Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Avon Products Dermatology OTC medications Main Business and Markets Served
-
11.11.4 Avon Products Dermatology OTC medications Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Edgewell Personal Care
-
11.12.1 Edgewell Personal Care Company Details
-
11.12.2 Edgewell Personal Care Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Edgewell Personal Care Dermatology OTC medications Main Business and Markets Served
-
11.12.4 Edgewell Personal Care Dermatology OTC medications Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 COOLA SUNCARE
-
11.13.1 COOLA SUNCARE Company Details
-
11.13.2 COOLA SUNCARE Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 COOLA SUNCARE Dermatology OTC medications Main Business and Markets Served
-
11.13.4 COOLA SUNCARE Dermatology OTC medications Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Beiersdorf
-
11.14.1 Beiersdorf Company Details
-
11.14.2 Beiersdorf Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Beiersdorf Dermatology OTC medications Main Business and Markets Served
-
11.14.4 Beiersdorf Dermatology OTC medications Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Lancaster Beauty
-
11.15.1 Lancaster Beauty Company Details
-
11.15.2 Lancaster Beauty Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Lancaster Beauty Dermatology OTC medications Main Business and Markets Served
-
11.15.4 Lancaster Beauty Dermatology OTC medications Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Bayer
-
11.16.1 Bayer Company Details
-
11.16.2 Bayer Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Bayer Dermatology OTC medications Main Business and Markets Served
-
11.16.4 Bayer Dermatology OTC medications Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Obagi Medical Products
-
11.17.1 Obagi Medical Products Company Details
-
11.17.2 Obagi Medical Products Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Obagi Medical Products Dermatology OTC medications Main Business and Markets Served
-
11.17.4 Obagi Medical Products Dermatology OTC medications Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Johnson & Johnson
-
11.18.1 Johnson & Johnson Company Details
-
11.18.2 Johnson & Johnson Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Johnson & Johnson Dermatology OTC medications Main Business and Markets Served
-
11.18.4 Johnson & Johnson Dermatology OTC medications Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Avene
-
11.19.1 Avene Company Details
-
11.19.2 Avene Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Avene Dermatology OTC medications Main Business and Markets Served
-
11.19.4 Avene Dermatology OTC medications Product Portfolio
-
11.19.5 Recent Research and Development Strategies
12 Global Dermatology OTC medications Market Outlook by Types and Applications to 2028
-
12.1 Global Dermatology OTC medications Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Sun screens Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Anti-aging Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Wrinkle cream Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Acne Treatment Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Dermatology OTC medications Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global male Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global female Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Dermatology OTC medications Market Analysis and Outlook to 2028
-
13.1 Global Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.2.2 Canada Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.2.3 Mexico Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.3.2 UK Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.3.3 Spain Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.3.4 Belgium Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.3.5 France Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.3.6 Italy Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.3.7 Denmark Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.3.8 Finland Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.3.9 Norway Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.3.10 Sweden Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.3.11 Poland Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.3.12 Russia Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.3.13 Turkey Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.4.2 Japan Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.4.3 India Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.4.4 South Korea Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.4.8 Thailand Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.4.9 Singapore Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.4.11 Philippines Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.5.2 Colombia Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.5.3 Chile Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.5.4 Argentina Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.5.6 Peru Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.6.3 Oman Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.6.4 Qatar Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.7.2 South Africa Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.7.3 Egypt Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.7.4 Algeria Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Dermatology OTC medications Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Dermatology OTC medications Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Dermatology OTC medications
-
Figure of Dermatology OTC medications Picture
-
Table Global Dermatology OTC medications Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Dermatology OTC medications Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Sun screens Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-aging Consumption and Growth Rate (2017-2022)
-
Figure Global Wrinkle cream Consumption and Growth Rate (2017-2022)
-
Figure Global Acne Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global others Consumption and Growth Rate (2017-2022)
-
Figure Global male Consumption and Growth Rate (2017-2022)
-
Figure Global female Consumption and Growth Rate (2017-2022)
-
Figure Global Dermatology OTC medications Consumption by Country (2017-2022)
-
Table North America Dermatology OTC medications Consumption by Country (2017-2022)
-
Figure United States Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Canada Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Mexico Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Table Europe Dermatology OTC medications Consumption by Country (2017-2022)
-
Figure Germany Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure UK Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Spain Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Belgium Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure France Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Italy Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Denmark Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Finland Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Norway Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Sweden Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Poland Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Russia Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Turkey Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Table APAC Dermatology OTC medications Consumption by Country (2017-2022)
-
Figure China Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Japan Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure India Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure South Korea Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Thailand Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Singapore Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Philippines Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Table South America Dermatology OTC medications Consumption by Country (2017-2022)
-
Figure Brazil Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Colombia Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Chile Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Argentina Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Peru Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Table GCC Dermatology OTC medications Consumption by Country (2017-2022)
-
Figure Bahrain Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Oman Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Qatar Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Table Africa Dermatology OTC medications Consumption by Country (2017-2022)
-
Figure Nigeria Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure South Africa Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Egypt Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure Algeria Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Table Oceania Dermatology OTC medications Consumption by Country (2017-2022)
-
Figure Australia Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Dermatology OTC medications Consumption and Growth Rate (2017-2022)
-
Table Sisley Paris Company Details
-
Table Sisley Paris Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sisley Paris Dermatology OTC medications Main Business and Markets Served
-
Table Sisley Paris Dermatology OTC medications Product Portfolio
-
Table Shiseido Company Details
-
Table Shiseido Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shiseido Dermatology OTC medications Main Business and Markets Served
-
Table Shiseido Dermatology OTC medications Product Portfolio
-
Table Amway Company Details
-
Table Amway Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amway Dermatology OTC medications Main Business and Markets Served
-
Table Amway Dermatology OTC medications Product Portfolio
-
Table Proctor & Gamble Company Details
-
Table Proctor & Gamble Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Proctor & Gamble Dermatology OTC medications Main Business and Markets Served
-
Table Proctor & Gamble Dermatology OTC medications Product Portfolio
-
Table loreal Company Details
-
Table loreal Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table loreal Dermatology OTC medications Main Business and Markets Served
-
Table loreal Dermatology OTC medications Product Portfolio
-
Table Lotus Herbals Company Details
-
Table Lotus Herbals Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lotus Herbals Dermatology OTC medications Main Business and Markets Served
-
Table Lotus Herbals Dermatology OTC medications Product Portfolio
-
Table Clinique Laboratories Company Details
-
Table Clinique Laboratories Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Clinique Laboratories Dermatology OTC medications Main Business and Markets Served
-
Table Clinique Laboratories Dermatology OTC medications Product Portfolio
-
Table Clarins Company Details
-
Table Clarins Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Clarins Dermatology OTC medications Main Business and Markets Served
-
Table Clarins Dermatology OTC medications Product Portfolio
-
Table Revlon Company Details
-
Table Revlon Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Revlon Dermatology OTC medications Main Business and Markets Served
-
Table Revlon Dermatology OTC medications Product Portfolio
-
Table Sebapharma Company Details
-
Table Sebapharma Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sebapharma Dermatology OTC medications Main Business and Markets Served
-
Table Sebapharma Dermatology OTC medications Product Portfolio
-
Table Avon Products Company Details
-
Table Avon Products Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Avon Products Dermatology OTC medications Main Business and Markets Served
-
Table Avon Products Dermatology OTC medications Product Portfolio
-
Table Edgewell Personal Care Company Details
-
Table Edgewell Personal Care Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Edgewell Personal Care Dermatology OTC medications Main Business and Markets Served
-
Table Edgewell Personal Care Dermatology OTC medications Product Portfolio
-
Table COOLA SUNCARE Company Details
-
Table COOLA SUNCARE Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table COOLA SUNCARE Dermatology OTC medications Main Business and Markets Served
-
Table COOLA SUNCARE Dermatology OTC medications Product Portfolio
-
Table Beiersdorf Company Details
-
Table Beiersdorf Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beiersdorf Dermatology OTC medications Main Business and Markets Served
-
Table Beiersdorf Dermatology OTC medications Product Portfolio
-
Table Lancaster Beauty Company Details
-
Table Lancaster Beauty Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lancaster Beauty Dermatology OTC medications Main Business and Markets Served
-
Table Lancaster Beauty Dermatology OTC medications Product Portfolio
-
Table Bayer Company Details
-
Table Bayer Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Dermatology OTC medications Main Business and Markets Served
-
Table Bayer Dermatology OTC medications Product Portfolio
-
Table Obagi Medical Products Company Details
-
Table Obagi Medical Products Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Obagi Medical Products Dermatology OTC medications Main Business and Markets Served
-
Table Obagi Medical Products Dermatology OTC medications Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Dermatology OTC medications Main Business and Markets Served
-
Table Johnson & Johnson Dermatology OTC medications Product Portfolio
-
Table Avene Company Details
-
Table Avene Dermatology OTC medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Avene Dermatology OTC medications Main Business and Markets Served
-
Table Avene Dermatology OTC medications Product Portfolio
-
Figure Global Sun screens Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-aging Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Wrinkle cream Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acne Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global male Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global female Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dermatology OTC medications Consumption Forecast by Country (2022-2028)
-
Table North America Dermatology OTC medications Consumption Forecast by Country (2022-2028)
-
Figure United States Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Dermatology OTC medications Consumption Forecast by Country (2022-2028)
-
Figure Germany Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Dermatology OTC medications Consumption Forecast by Country (2022-2028)
-
Figure China Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Dermatology OTC medications Consumption Forecast by Country (2022-2028)
-
Figure Brazil Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Dermatology OTC medications Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Dermatology OTC medications Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Dermatology OTC medications Consumption Forecast by Country (2022-2028)
-
Figure Australia Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Dermatology OTC medications Consumption Forecast and Growth Rate (2022-2028)
-
